Second Regular Session H.B. 2633
PROPOSED
SENATE AMENDMENTS TO H.B. 2633
(Reference to House engrossed bill)
Page 7, line 2, after the period insert "The board or the executive director, if delegated by the board, may waive the red cap requirement if implementing the requirement is not feasible because of the specific dosage form or packaging type."
Amend title to conform